Titan Pharmaceuticals Stock In The News

TTNP Stock  USD 3.63  0.04  1.11%   
The analysis of Titan Pharmaceuticals' news coverage and content from conventional and social sources shows investors' indifference towards Titan Pharmaceuticals. The specific impact of Titan Pharmaceuticals news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Titan Pharmaceuticals' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Titan Pharmaceuticals headlines in addition to utilizing other, more conventional financial analysis modules. Check out Titan Pharmaceuticals Backtesting and Titan Pharmaceuticals Hype Analysis.
To learn how to invest in Titan Stock, please use our How to Invest in Titan Pharmaceuticals guide.

Titan Pharmaceuticals Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
Titan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company's Board of Directors
https://www.globenewswire.com/news-release/2023/10/16/2761085/0/en/Titan-Pharmaceuticals-Announces-Appointment-of-Dato-Seow-Gim-Shen-and-Brynner-Chaim-to-the-Company-s-Board-of-Directors.html
 Neutral
Macroaxis News: globenewswire.com
Titan Pharmaceuticals Announces $9.5 Million Private Placement of Convertible Preferred Stock
https://www.globenewswire.com/news-release/2023/09/18/2744665/0/en/Titan-Pharmaceuticals-Announces-9-5-Million-Private-Placement-of-Convertible-Preferred-Stock.html
 Bullish
Macroaxis News: globenewswire.com
Titan Pharmaceuticals Announces Sale of Certain ProNeura Assets
https://www.globenewswire.com/news-release/2023/07/27/2712070/0/en/Titan-Pharmaceuticals-Announces-Sale-of-Certain-ProNeura-Assets.html
 Bullish
Macroaxis News: globenewswire.com
Titan Pharmaceuticals Provides Shareholder Update
https://www.globenewswire.com/news-release/2022/12/15/2574394/0/en/Titan-Pharmaceuticals-Provides-Shareholder-Update.html
 Bullish
Macroaxis News: globenewswire.com
UPDATE -- Titan Pharmaceuticals Inc. Announces Licensing Agreement with Ocular Therapeutix Inc.
https://www.globenewswire.com/news-release/2022/12/12/2571764/0/en/UPDATE-Titan-Pharmaceuticals-Inc-Announces-Licensing-Agreement-with-Ocular-Therapeutix-Inc.html
 Bullish
Macroaxis News: globenewswire.com
Titan Pharmaceuticals Inc. Announces Licensing Agreement with Ocular Therapeutix Inc.
https://www.globenewswire.com/news-release/2022/12/12/2571657/0/en/Titan-Pharmaceuticals-Inc-Announces-Licensing-Agreement-with-Ocular-Therapeutix-Inc.html
 Bullish
Macroaxis News: globenewswire.com
Activist Investing Nominates Slate of Hi...
https://www.globenewswire.com/news-release/2022/07/11/2477242/0/en/Activist-Investing-Nominates-Slate-of-Highly-Qualified-Director-Candidates-for-Election-to-the-Board-of-Directors-of-Titan-Pharmaceuticals-at-Upcoming-Special-Meeting-of-Stockholde.html
 Bullish
Macroaxis News: globenewswire.com
Activist Investing Discloses 9.9% Ownership Interest in Titan Pharmaceuticals, Inc.
https://www.globenewswire.com/news-release/2022/06/10/2460451/0/en/Activist-Investing-Discloses-9-9-Ownership-Interest-in-Titan-Pharmaceuticals-Inc.html
 Bullish
Macroaxis News: globenewswire.com
Activist Investing Announces 5.6% Ownership Interest in Titan Pharmaceuticals, Inc.
https://www.globenewswire.com/news-release/2022/04/25/2428455/0/en/Activist-Investing-Announces-5-6-Ownership-Interest-in-Titan-Pharmaceuticals-Inc.html
 Bullish
Yahoo News
Titan Pharmaceuticals Announces Pricing of $5.5 Million Registered Direct and PIPE Offering Priced At-The-Market
https://finance.yahoo.com/news/titan-pharmaceuticals-announces-pricing-5-134500770.html
 Bullish

Titan Pharmaceuticals Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Titan and other traded companies coverage with news coverage. We help investors stay connected with Titan headlines for the 14th of March 2025 to make an informed investment decision based on correlating the impacts of news items on Titan Stock performance. Please note that trading solely based on the Titan Pharmaceuticals hype is not for everyone as timely availability and quick action are needed to avoid losses.
Titan Pharmaceuticals' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Titan Pharmaceuticals investors visualize upcoming and past events in order to time the market based on Titan Pharmaceuticals noise-free hype analysis.
Titan Pharmaceuticals stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Titan earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Titan Pharmaceuticals that are available to investors today. That information is available publicly through Titan media outlets and privately through word of mouth or via Titan internal channels. However, regardless of the origin, that massive amount of Titan data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Titan Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Titan Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Titan Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Titan Pharmaceuticals alpha.

Titan Largest EPS Surprises

Earnings surprises can significantly impact Titan Pharmaceuticals' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2022-11-10
2022-09-30-0.21-0.180.0314 
2023-03-31
2022-12-31-0.22-0.180.0418 
2022-08-17
2022-06-30-0.26-0.180.0830 
2021-11-15
2021-09-30-0.35-0.190.1645 
2021-08-16
2021-06-30-0.35-0.170.1851 
2020-11-16
2020-09-30-1.05-1.5-0.4542 
View All Earnings Estimates

Titan Pharmaceuticals Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Titan Pharmaceuticals Stock. Current markets are strongly bullish. About 93% of major world exchanges and indexes are currently up. See today's market update for more information.
Google News at Macroaxis
10th of March 2025
PHIO - Phio Pharmaceuticals Corp Latest Stock News Market Updates - StockTitan
at news.google.com 
Macroaxis News
3rd of March 2025
Disposition of tradable shares by Chasey Peter Louis of Titan Pharmaceuticals subject to R...
at MacroaxisInsider 
Google News at Macroaxis
3rd of January 2025
Titan Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months...
at news.google.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Titan Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Titan Pharmaceuticals' short interest history, or implied volatility extrapolated from Titan Pharmaceuticals options trading.

Additional Tools for Titan Stock Analysis

When running Titan Pharmaceuticals' price analysis, check to measure Titan Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Titan Pharmaceuticals is operating at the current time. Most of Titan Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Titan Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Titan Pharmaceuticals' price. Additionally, you may evaluate how the addition of Titan Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.